Clinical Trial

ACT Lung Health Intervention: Phase Two

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-18; most recent amendment 2026-03-11.
Status change: Not Yet Recruiting → Recruiting 2025-11-12
Trial Details
NCT Number NCT06945120
Lead Sponsor Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI), University of Massachusetts, Boston
Conditions Smoking Cessation, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette, Smoking (Tobacco) Addiction
Enrollment 50 participants
Start Date 2025-11-04
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-13